Thursday, 25 July 2013

CDER New July 25, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

July 24, 2013


New and Generic Drug Approvals

July 23, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Clarinex desloratadine Tablet; Oral Merck Sharp Dohme Manufacturing Change or Addition
Conray iothalamate meglumine Injectable; Injection Mallinckrodt Manufacturing Change or Addition
Conray 43 iothalamate meglumine Injectable; Injection Mallinckrodt Manufacturing Change or Addition
Cordran flurandrenolide Ointment; Topical Aqua Pharms Manufacturing Change or Addition
Cordran Sp flurandrenolide Cream; Topical Aqua Pharms Manufacturing Change or Addition
Edurant rilpivirine hydrochloride Tablet; Oral Janssen Prods Manufacturing Change or Addition
Epi E Z Pen Jr epinephrine Injectable; Intramuscular Meridian Medcl Techn Manufacturing Change or Addition
Epipen epinephrine Injectable; Intramuscular Meridian Medcl Techn Manufacturing Change or Addition
Epipen E Z Pen epinephrine Injectable; Intramuscular Meridian Medcl Techn Manufacturing Change or Addition
Epipen Jr. epinephrine Injectable; Intramuscular Meridian Medcl Techn Manufacturing Change or Addition
Gilotrif afatinib Tablet; Oral Boehringer Ingelheim Labeling Revision
Hylenex Recombinant hyaluronidase recombinant human Injectable; Injection Halozyme Therap Manufacturing Change or Addition
Pentasa mesalamine Capsule, Extended Release; Oral Shire Labeling Revision
Reclast zoledronic acid Injectable; Iv (Infusion) Novartis Manufacturing Change or Addition
Terazol 3 terconazole Suppository; Vaginal Janssen Pharms Manufacturing Change or Addition
Terazol 3 terconazole Cream; Vaginal Janssen Pharms Manufacturing Change or Addition
Terazol 7 terconazole Cream; Vaginal Janssen Pharms Manufacturing Change or Addition

 


This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

No comments:

Post a Comment